
Singular Genomics: A dynamic, fast-paced biotech company in California, innovating in genomic technologies.
Singular Genomics, founded in La Jolla, California, is a venture capital-backed biotech company focused on advancing genomic technologies. Their core mission is to drive innovation in multiomic discovery through high-throughput sequencing solutions. Singular Genomics offers products like the G4X platform, which integrates high-throughput in-situ spatial sequencing with next-gen sequencing capabilities, targeting researchers and institutions involved in genomic and multiomic analysis.
Notable affiliated individuals include experienced biotech entrepreneurs and scientists who contribute to the company's dynamic and results-oriented environment. Singular Genomics has attracted significant venture capital investment, enabling rapid growth and development. Their key achievements include the successful launch of the G4X platform, which has set new standards in spatial sequencing and multiomic analysis. The company’s impact is marked by its contributions to advancing genomic research and providing cutting-edge tools for scientific discovery.

10x Genomics
10xgenomics.com

Spatial Genomics

BioSkryb Genomics
bioskryb.com

Pacific Biosciences of California

Streamline Genomics

Jumpcode Genomics

Sequegenics
sequegenics.com

Arima Genomics
arimagenomics.com

MicroPure Genomics

XGenomes
xgenomes.com

Element Biosciences

Geneicd

GenomeNext

Pleno
plenoinc.com

Paragon Genomics
Companies similar to Singular Genomics include 10x Genomics, Spatial Genomics, BioSkryb Genomics and Pacific Biosciences of California.
Singular Genomics was founded in 2016.
Singular Genomics' headquarters is located in San Diego, CA, US.
Singular Genomics' most recent funding round was for $130.5M (USD) in May 2021.
As of May 12, 2021, Singular Genomics has raised a total of $176M (USD).
Singular Genomics has 134 employees as of Feb 6, 2024.